Jones Financial Companies’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.11M Buy
68,803
+27,397
+66% +$3.32M ﹤0.01% 1036
2026
Q1
$6.02M Buy
41,406
+40,854
+7,401% +$6.28M ﹤0.01% 1006
2025
Q4
$96.1K Buy
552
+4
+0.7% +$730 ﹤0.01% 2232
2025
Q3
$75.4K Buy
548
+382
+230% +$46.8K ﹤0.01% 2196
2025
Q2
$16.6K Buy
166
+45
+37% +$3.44K ﹤0.01% 2679
2025
Q1
$9.44K Sell
121
-15
-11% -$1.15K ﹤0.01% 2737
2024
Q4
$9.39K Buy
+136
New +$9.79K ﹤0.01% 2548

Other funds holding INSM

Jones Financial Companies's INSM Position: Q2 2026 in Review

Jones Financial Companies increased its Insmed (INSM) stake by 66% in Q2 2026, buying an estimated $3.32M and bringing the position to 68,803 shares worth $7.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Jones Financial Companies first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Jones Financial Companies held 68,803 shares of Insmed worth $7.11M as of Q2 2026.
  • Jones Financial Companies bought 27,397 Insmed shares in Q2 2026, an estimated $3.32M.
  • Insmed made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1036 holding.
  • Jones Financial Companies first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.